Exploratory Clinical Study to Evaluate the Optimal Dosage of Mosapride and Probiotics in Irritable Bowel Syndrome Without Predominant Diarrhea
Clinical trial NCT01505777 · COMPLETED
Trial details
- NCT number
- NCT01505777
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2012-06-01
- Enrollment
- 280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.